Our Commitment to Transparency

Transparency is inherent in our commitment to serve the patient by creating a vibrant, inventive and ethical culture that will help people lead better, fuller lives today, tomorrow and well into the future. Shire is committed to responsible sharing of clinical study data.

Baxalta-Sponsored Clinical Study Report Synopses

Clinical Study Report (CSR) synopses provide a short overview of the purpose and results of the clinical trial. Synopses from certain Baxalta, now a part of Shire, sponsored clinical trials for medicines/indications that were approved in the U.S. and E.U. on or after January 1, 2014 are available. A link to CSR data on publicly accessible online registries (e.g. www.clinicaltrials.govwww.clinicaltrialsregister.eu) are also posted.

For general information on Baxalta's ongoing clinical trials, you may also visit the National Institutes of Health's Clinical Trials page at www.clinicaltrials.gov, the EU Clinical Trials Register site at www.clinicaltrialsregister.eu, and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance at www.encepp.eu.